ArticleOncotarget2017
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study.
Jian Ming Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it